Publicacións en colaboración con investigadores/as de Instituto Oftalmológico Gómez-Ulla, Santiago de Compostela (11)

2024

  1. Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab

    Pharmaceuticals, Vol. 17, Núm. 2

  2. The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration

    Pharmaceutics, Vol. 16, Núm. 1

2023

  1. Análisis coste-utilidad del modelo de unidad de terapia intravítrea (UTI) frente a la administración tradicional de terapia intravítrea

    Archivos de la Sociedad Española de Oftalmologia, Vol. 98, Núm. 11, pp. 619-626

  2. Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration

    Investigative ophthalmology & visual science, Vol. 64, Núm. 13, pp. 34

2021

  1. Recomendaciones «no hacer» para retinopatías: estudio mixto de consenso

    Archivos de la Sociedad Española de Oftalmologia, Vol. 96, Núm. 11, pp. 578-586

2020

  1. Pharmacological advances in the treatment of age-related macular degeneration

    Current Medicinal Chemistry, Vol. 27, Núm. 4, pp. 583-598

2019

  1. A novel automatic method to estimate visual acuity and analyze the retinal vasculature in retinal vein occlusion using swept source optical coherence tomography angiography

    Journal of Clinical Medicine, Vol. 8, Núm. 10

  2. Multimodality Imaging Approach for Combined Central Retinal Vein and Artery Occlusion: The Role of Optical Coherence Tomography Angiography

    Case Reports in Ophthalmology, Vol. 10, Núm. 3, pp. 415-423

2017

  1. In Vitro Evaluation of the Ophthalmic Toxicity Profile of Chlorhexidine and Propamidine Isethionate Eye Drops

    Journal of Ocular Pharmacology and Therapeutics, Vol. 33, Núm. 3, pp. 202-209

2015

  1. Acute loss of vision after an intravitreal injection ocriplasmin: a functional evolutionary study for 1-year follow-up

    Documenta Ophthalmologica, Vol. 131, Núm. 3, pp. 231-235

  2. In vitro and in vivo ocular safety and eye surface permanence determination by direct and Magnetic Resonance Imaging of ion-sensitive hydrogels based on gellan gum and kappa-carrageenan

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 94, pp. 342-351